The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
Background: MS is a highly heterogeneous disease, both in its course and in its response to treatments. Effective biomarkers may help predict disability progression and monitor patients’ treatment responses. <br/>Objective: To focus on how biomarkers may contribute to treatment individualisat...
Prif Awduron: | Vermersch, P, Berger, T, Gold, R, Lukas, C, Rovira, A, Meesen, B, Chard, D, Comabella, M, Palace, J, Trojano, M |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
SAGE Publications
2016
|
Eitemau Tebyg
-
Personalised CLIP or: how to find your vacation videos
gan: Korbar, B, et al.
Cyhoeddwyd: (2022) -
How to build personalised multi-omics comorbidity profiles
gan: Mohammad Ali eMoni, et al.
Cyhoeddwyd: (2015-06-01) -
How personalised medicine will transform healthcare by 2030: the ICPerMed vision
gan: Astrid M. Vicente, et al.
Cyhoeddwyd: (2020-04-01) -
Sleep apnoea syndrome: how will physiologic knowledge position personalised medicine?
gan: F. Sériès
Cyhoeddwyd: (2011-09-01) -
Biomarkers in Psoriasis: The Future of Personalised Treatment
gan: Bikash R. Kar, et al.
Cyhoeddwyd: (2024-06-01)